Vir Biotechnology (VIR) FCF Margin (QoQ) (2019 - 2026)
Vir Biotechnology (VIR) FCF Margin (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Vir Biotechnology |
1.35 Bn |
1.35 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-45.78 Mn |
| Dec 31, 2025 |
6.99 Mn |
| Sep 30, 2025 |
-5.98 Mn |
| Jun 30, 2025 |
-748,167.00 |
| Mar 31, 2025 |
-190,577.00 |
| Dec 31, 2024 |
659,700.00 |
| Sep 30, 2024 |
-476,808.00 |
| Jun 30, 2024 |
-233,806.00 |
| Mar 31, 2024 |
43,686.00 |
| Dec 31, 2023 |
539,352.00 |
| Sep 30, 2023 |
445,491.00 |
| Jun 30, 2023 |
-1.03 Mn |
| Mar 31, 2023 |
-25,634.00 |
| Dec 31, 2022 |
1,924.00 |
| Sep 30, 2022 |
-228,607.00 |
| Jun 30, 2022 |
226,913.00 |
| Mar 31, 2022 |
4,401.00 |
| Dec 31, 2021 |
10,751.00 |
| Sep 30, 2021 |
-19,013.00 |
| Jun 30, 2021 |
463,192.00 |
